Get access

Upregulation of Immunoglobulin-related Genes in Cortical Sections from Multiple Sclerosis Patients

Authors

  • Øivind Torkildsen,

    Corresponding author
    1. Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
    2. Department of Clinical Medicine, University of Bergen, Bergen, Norway.
    Search for more papers by this author
    • Authors contributed equally to this work.

  • Christine Stansberg,

    1. Dr E. Martens Research Group for Biological Psychiatry and Bergen Mental Health Research Centre, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
    2. Centre for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
    Search for more papers by this author
    • Authors contributed equally to this work.

  • Solveig M. Angelskår,

    1. Dr E. Martens Research Group for Biological Psychiatry and Bergen Mental Health Research Centre, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
    2. Centre for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
    Search for more papers by this author
  • Evert-Jan Kooi,

    1. Department of Pathology, and
    Search for more papers by this author
  • Jeroen J.G. Geurts,

    1. Department of Pathology, and
    2. Department of Radiology, VU University Medical Center, Amsterdam, the Netherlands.
    Search for more papers by this author
  • Paul Van Der Valk,

    1. Department of Pathology, and
    Search for more papers by this author
  • Kjell-Morten Myhr,

    1. Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
    2. Department of Clinical Medicine, University of Bergen, Bergen, Norway.
    Search for more papers by this author
  • Vidar M. Steen,

    1. Dr E. Martens Research Group for Biological Psychiatry and Bergen Mental Health Research Centre, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
    2. Centre for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
    Search for more papers by this author
  • Lars Bø

    1. Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
    2. Department of Clinical Medicine, University of Bergen, Bergen, Norway.
    Search for more papers by this author

Øivind Torkildsen, MD, Department of Neurology, Haukeland University Hospital, N-5021 Bergen, Norway (E-mail: oivind.torkildsen@gmail.com)

Abstract

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). Microarray-based global gene expression profiling is a promising method, used to study potential genes involved in the pathogenesis of the disease. In the present study, we have examined global gene expression in normal-appearing gray matter and gray matter lesions from the cortex of MS patients, and compared them with cortical gray matter samples from controls. We observed a massive upregulation of immunoglobulin (Ig)-related genes in cortical sections of MS patients. Using immunohistochemistry, the activation of Ig genes seems to occur within plasma cells in the meninges. As synthesis of oligoclonal IgGs has been hypothesized to be caused by the activation of Epstein–Barr virus (EBV)-infected B-cells, we screened the brain samples for the presence of EBV by real-time quantitative polymerase chain reaction (qPCR) and immunohistochemistry, but no evidence of active or latent EBV infection was detected. This study demonstrates that genes involved in the synthesis of Igs are upregulated in MS patients and that this activation is caused by a small number of meningeal plasma cells that are not infected by EBV. The findings indicate that the Ig-producing B-cells found in the cerebrospinal fluid (CSF) of MS patients could have meningeal origin.

Ancillary